Publication date: Jun 03, 2025
This prospective longitudinal study aimed to evaluate the impact of COVID-19 on glycemic control and hematological parameters in patients with pre-existing type 2 diabetes. Data for this study was collected from outpatient Endocrinology Departments of tertiary and secondary care hospitals in Islamabad, Pakistan, between November 2022 and April 2024. Out of the 604 patients initially enrolled, only 420 completed the nine-month study with full clinical data across three follow-up visits and were included in the final analysis. At baseline, COVID-19-positive type 2 diabetes patients (case group) exhibited significantly higher HbA1c, and random blood glucose levels with lower white blood cell, red blood cell, hemoglobin, and platelet counts (p
| Concepts | Keywords |
|---|---|
| Completed | Coronavirus |
| Diabetes | COVID-19 |
| Hematological | HbA1c |
| November | RBC |
| Pakistan | RBG |
| type 2 diabetes |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | MESH | type 2 diabetes |
| disease | IDO | blood |
| disease | IDO | cell |